US4418068A
(en)
*
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
GB2097788B
(en)
*
|
1981-04-03 |
1985-04-24 |
Lilly Co Eli |
Benzothiophene compounds and process for preparing them
|
IL65378A
(en)
|
1981-04-03 |
1986-02-28 |
Lilly Co Eli |
Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
|
US4358593A
(en)
*
|
1981-04-03 |
1982-11-09 |
Eli Lilly And Company |
Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
|
IL65379A0
(en)
*
|
1981-04-03 |
1982-05-31 |
Lilly Co Eli |
Process for preparing acylated benzothiophenes
|
US4380635A
(en)
*
|
1981-04-03 |
1983-04-19 |
Eli Lilly And Company |
Synthesis of acylated benzothiophenes
|
US4656187A
(en)
*
|
1981-08-03 |
1987-04-07 |
Eli Lilly And Company |
Treatment of mammary cancer
|
NO174506B
(no)
*
|
1984-10-30 |
1994-02-07 |
Usv Pharma Corp |
Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
|
DE4117512A1
(de)
*
|
1991-05-25 |
1992-11-26 |
Schering Ag |
2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
|
US6515009B1
(en)
*
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
JP3157882B2
(ja)
*
|
1991-11-15 |
2001-04-16 |
帝国臓器製薬株式会社 |
新規なベンゾチオフエン誘導体
|
US5196435A
(en)
*
|
1991-11-21 |
1993-03-23 |
Eli Lilly And Company |
Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
USRE39049E1
(en)
*
|
1992-07-28 |
2006-03-28 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
USRE38968E1
(en)
*
|
1992-07-28 |
2006-02-07 |
Eli Lilly And Company |
Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6395494B1
(en)
*
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US5770609A
(en)
*
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
TW383306B
(en)
*
|
1992-12-22 |
2000-03-01 |
Lilly Co Eli |
New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5595722A
(en)
*
|
1993-01-28 |
1997-01-21 |
Neorx Corporation |
Method for identifying an agent which increases TGF-beta levels
|
US5482949A
(en)
*
|
1993-03-19 |
1996-01-09 |
Eli Lilly And Company |
Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
|
JPH08510451A
(ja)
*
|
1993-05-13 |
1996-11-05 |
ネオルックス コーポレイション |
異常増殖性平滑筋細胞に関連した病因の予防及び治療
|
IL109990A
(en)
*
|
1993-06-21 |
1999-06-20 |
Lilly Co Eli |
Materials and methods for screening anti-osteoporosis agents
|
ES2105525T3
(es)
*
|
1993-06-24 |
1997-10-16 |
Lilly Co Eli |
2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
|
TW303299B
(fr)
*
|
1993-07-22 |
1997-04-21 |
Lilly Co Eli |
|
US6756388B1
(en)
*
|
1993-10-12 |
2004-06-29 |
Pfizer Inc. |
Benzothiophenes and related compounds as estrogen agonists
|
US5482950A
(en)
*
|
1993-10-15 |
1996-01-09 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
IL111287A0
(en)
*
|
1993-10-15 |
1994-12-29 |
Lilly Co Eli |
Methods for treating resistant neoplasms
|
US5457113A
(en)
*
|
1993-10-15 |
1995-10-10 |
Eli Lilly And Company |
Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
|
US5461065A
(en)
*
|
1993-10-15 |
1995-10-24 |
Eli Lilly And Company |
Methods for inhibiting endometriosis
|
US5441964A
(en)
*
|
1993-10-15 |
1995-08-15 |
Eli Lilly And Company |
Methods for inhibiting bone loss using substituted benzothiophene
|
US5418252A
(en)
*
|
1993-10-15 |
1995-05-23 |
Eli Lilly And Company |
Method for inhibiting cartilage degradation
|
US5457116A
(en)
*
|
1993-10-15 |
1995-10-10 |
Eli Lilly And Company |
Methods of inhibiting uterine fibrosis
|
UA32427C2
(uk)
*
|
1993-10-15 |
2000-12-15 |
Елі Ліллі Енд Компані |
Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань
|
US5391557A
(en)
*
|
1993-10-15 |
1995-02-21 |
Eli Lilly And Company |
Methods for the treatment of peri-menopausal syndrome
|
US5480904A
(en)
*
|
1993-10-28 |
1996-01-02 |
Eli Lilly And Company |
Methods for inhibiting uterine fibrosis
|
US6489355B2
(en)
*
|
1993-12-01 |
2002-12-03 |
Eli Lilly And Company |
Methods of inhibiting the effects of amyloidogenic proteins
|
US5476862A
(en)
*
|
1993-12-21 |
1995-12-19 |
Eli Lilly And Company |
Methods of increasing thrombomodulin expression
|
US5462949A
(en)
*
|
1993-12-21 |
1995-10-31 |
Eli Lilly And Company |
Methods of inhibiting fertility in women
|
US5574047A
(en)
*
|
1993-12-21 |
1996-11-12 |
Eli Lilly And Company |
Methods of inhibiting imperfect tissue repair
|
US5439923A
(en)
*
|
1993-12-21 |
1995-08-08 |
Eli Lilly And Company |
Method of inhibiting seborrhea and acne
|
CA2176130A1
(fr)
*
|
1993-12-21 |
1995-06-29 |
Thomas Alan Crowell |
Antagonistes non peptidiques des recepteurs des tachykinines
|
US5534526A
(en)
*
|
1993-12-21 |
1996-07-09 |
Eli Lilly And Company |
Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
|
US5447941A
(en)
*
|
1993-12-21 |
1995-09-05 |
Eli Lilly And Company |
Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
|
US5492927A
(en)
*
|
1993-12-21 |
1996-02-20 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists to treat allergy
|
JPH07196494A
(ja)
*
|
1993-12-21 |
1995-08-01 |
Eli Lilly & Co |
強迫性障害および消費性障害を抑制するための医薬組成物
|
US5708009A
(en)
*
|
1993-12-21 |
1998-01-13 |
Eli Lilly And Company |
Methods of inhibiting myeloperoxidase activity
|
US5451590A
(en)
*
|
1993-12-21 |
1995-09-19 |
Eli Lilly & Co. |
Methods of inhibiting sexual precocity
|
US5439931A
(en)
*
|
1993-12-21 |
1995-08-08 |
Eli Lilly And Company |
Method for increasing libido in post-menopausal women
|
US5441966A
(en)
*
|
1993-12-21 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting Turner's syndrome
|
US5578613A
(en)
*
|
1993-12-21 |
1996-11-26 |
Eli Lilly And Company |
Methods for inhibiting weight gain or inducing weight loss
|
CZ321394A3
(en)
*
|
1993-12-21 |
1995-08-16 |
Lilly Co Eli |
Pharmaceutical preparation for inhibiting woman hirsutism and alopecia
|
US5446053A
(en)
*
|
1993-12-21 |
1995-08-29 |
Eli Lilly And Company |
Methods of inhibiting dysfunctional uterine bleeding
|
US5461064A
(en)
*
|
1993-12-21 |
1995-10-24 |
Eli Lilly And Company |
Methods of inhibiting atrophy of the skin and vagina
|
US6417198B1
(en)
|
1993-12-21 |
2002-07-09 |
Eli Lilly And Company |
Methods of inhibiting CNS problems in post-menopausal women
|
US5552415A
(en)
*
|
1993-12-21 |
1996-09-03 |
Eli Lilly And Company |
Method of inhibiting Alzheimer's Disease
|
US5672610A
(en)
*
|
1993-12-21 |
1997-09-30 |
Eli Lilly And Company |
Methods of increasing macrophage function
|
US5389670A
(en)
*
|
1993-12-21 |
1995-02-14 |
Eli Lilly Company |
Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
|
US5441965A
(en)
*
|
1993-12-21 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting thrombin
|
US5596004A
(en)
*
|
1993-12-21 |
1997-01-21 |
Eli Lilly And Company |
Methods of inhibiting male infertility
|
US5462950A
(en)
*
|
1993-12-21 |
1995-10-31 |
Eli Lilly And Company |
Methods of treating menstrual symptoms and compositions therefore
|
US5521198A
(en)
|
1993-12-21 |
1996-05-28 |
Eli Lilly And Company |
Methods of inhibiting autoimmune diseases
|
JPH09507071A
(ja)
*
|
1993-12-21 |
1997-07-15 |
イーライ・リリー・アンド・カンパニー |
アミロイド原性ペプチドに関連した状態を治療又は予防する方法
|
US5451589A
(en)
*
|
1993-12-21 |
1995-09-19 |
Eli Lilly And Company |
Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
|
US5593987A
(en)
*
|
1993-12-21 |
1997-01-14 |
Eli Lilly And Company |
Methods of inhibiting breast disorders
|
US5591753A
(en)
*
|
1994-01-28 |
1997-01-07 |
Eli Lilly And Company |
Combination treatment for osteoporosis
|
US5811120A
(en)
*
|
1994-03-02 |
1998-09-22 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5478847A
(en)
*
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
US5972383A
(en)
*
|
1994-03-02 |
1999-10-26 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
CA2145614A1
(fr)
*
|
1994-03-31 |
1995-10-01 |
Jeffrey A. Dodge |
Intermediaires et procedes pour la preparation de benzothiofenes
|
US5604248A
(en)
*
|
1994-05-05 |
1997-02-18 |
Eli Lilly And Company |
Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
|
US6723739B1
(en)
|
1994-05-20 |
2004-04-20 |
Eli Lilly And Company |
Glucopyranoside benzothiophenes
|
US5466810A
(en)
*
|
1994-06-10 |
1995-11-14 |
Eli Lilly And Company |
2-amino-3-aroyl-benzo[β]thiophenes and methods for preparing and using same to produce 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-aminoethoxy)-benzoyl]benzo[β]thiophenes
|
US5420349A
(en)
*
|
1994-06-10 |
1995-05-30 |
Eli Lilly And Company |
2-amino-3-aroyl-benzo[β]thiophenes and methods for preparing and using same to produce 6-hydroxy-2-(4-hydroxyphenyl)-3-]benzo[4-(2-aminoethoxy)-benzoyl[β]thiophenes
|
US5596106A
(en)
*
|
1994-07-15 |
1997-01-21 |
Eli Lilly And Company |
Cannabinoid receptor antagonists
|
US5523416A
(en)
*
|
1994-07-22 |
1996-06-04 |
Eli Lilly And Company |
Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
|
PL181304B1
(pl)
|
1994-07-22 |
2001-07-31 |
Lilly Co Eli |
Preparat farmaceutyczny do hamowania zmniejszania masy kosci PL PL PL PL PL PL PL PL PL PL
|
US5550123A
(en)
*
|
1994-08-22 |
1996-08-27 |
Eli Lilly And Company |
Methods for inhibiting bone prosthesis degeneration
|
US5550151A
(en)
*
|
1994-08-22 |
1996-08-27 |
Eli Lilly Company |
Methods of reducing scarring in wound healing
|
US5502074A
(en)
*
|
1994-08-22 |
1996-03-26 |
Eli Lilly And Company |
Benzothiophenes for bone healing and fracture repair
|
US5494920A
(en)
*
|
1994-08-22 |
1996-02-27 |
Eli Lilly And Company |
Methods of inhibiting viral replication
|
US5512296A
(en)
*
|
1994-08-22 |
1996-04-30 |
Eli Lilly And Company |
Methods for inhibiting neuronal damage
|
US5434166A
(en)
*
|
1994-08-22 |
1995-07-18 |
Eli Lilly And Company |
Methods of inhibiting demyelinating and desmyelinating diseases
|
US5496828A
(en)
*
|
1994-08-22 |
1996-03-05 |
Eli Lilly And Company |
Methods of inhibiting ulcerative mucositis
|
US5731436A
(en)
*
|
1994-08-31 |
1998-03-24 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
US5631369A
(en)
|
1994-08-31 |
1997-05-20 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
CO4410191A1
(es)
*
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
|
US5629425A
(en)
*
|
1994-09-19 |
1997-05-13 |
Eli Lilly And Company |
Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
|
US5492921A
(en)
*
|
1994-09-20 |
1996-02-20 |
Eli Lilly And Company |
Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation
|
US7501441B1
(en)
*
|
1994-09-20 |
2009-03-10 |
Eli Lilly And Company |
Naphthyl compounds, intermediates, processes, compositions, and methods
|
US5554628A
(en)
*
|
1994-09-20 |
1996-09-10 |
Eli Lilly And Company |
Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs
|
US6703407B1
(en)
|
1994-09-20 |
2004-03-09 |
Eli Lilly And Company |
Benzofuran compounds, compositions, and methods
|
US5658931A
(en)
*
|
1994-09-20 |
1997-08-19 |
Eli Lilly And Company |
Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds
|
US5843964A
(en)
*
|
1994-09-22 |
1998-12-01 |
Eli Lilly And Company |
Methods of inhibiting endometrial mitoses
|
EP0704393B1
(fr)
|
1994-09-28 |
1998-10-21 |
Mannesmann Dematic Rapistan Corp. |
Système de branchement pour convoyeurs
|
IL115582A0
(en)
*
|
1994-10-14 |
1996-01-19 |
Lilly Co Eli |
Methods for treating resistant tumors
|
AU3953695A
(en)
*
|
1994-10-20 |
1996-05-15 |
Eli Lilly And Company |
Bicyclic bradykinin receptor antagonists
|
US6562862B1
(en)
*
|
1994-10-20 |
2003-05-13 |
Eli Lilly And Company |
Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
|
US5545641A
(en)
*
|
1994-10-20 |
1996-08-13 |
Eli Lilly And Company |
Methods of inhibiting physiological conditions associated with an excess of bradykinin
|
IL115613A0
(en)
*
|
1994-10-20 |
1996-01-19 |
Lilly Co Eli |
Bicyclic neuropeptide y receptor antagonists
|
US5589482A
(en)
*
|
1994-12-14 |
1996-12-31 |
Pfizer Inc. |
Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
|
US5552412A
(en)
*
|
1995-01-09 |
1996-09-03 |
Pfizer Inc |
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
|
US5494929A
(en)
*
|
1995-01-12 |
1996-02-27 |
Eli Lilly And Company |
Methods of inhibiting growth hormone effects
|
US5521214A
(en)
*
|
1995-01-25 |
1996-05-28 |
Eli Lilly And Company |
Methods of inhibiting environmental estrogens
|
US5512583A
(en)
*
|
1995-01-30 |
1996-04-30 |
Eli Lilly And Company |
Methods of decreasing serum calcium levels
|
KR19980701933A
(ko)
*
|
1995-02-06 |
1998-06-25 |
피터 쥐. 스트링거 |
인터루킨-6의 작용의 억제 방법
|
US5484808A
(en)
*
|
1995-02-09 |
1996-01-16 |
Eli Lilly And Company |
Methods of inhibiting cell-cell adhesion
|
US20030083733A1
(en)
*
|
1997-10-10 |
2003-05-01 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5977093A
(en)
*
|
1995-02-28 |
1999-11-02 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
US5998441A
(en)
*
|
1995-02-28 |
1999-12-07 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
ZA961564B
(en)
*
|
1995-02-28 |
1997-08-27 |
Lilly Co Eli |
Methods of inhibiting ovarian cancer.
|
US6479517B1
(en)
|
1995-02-28 |
2002-11-12 |
Eli Lilly And Company |
Phosphorous-containing benzothiophenes
|
US5856339A
(en)
*
|
1995-02-28 |
1999-01-05 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
US5856340A
(en)
|
1995-02-28 |
1999-01-05 |
Eli Lilly And Company |
Method of treating estrogen dependent cancers
|
US5510357A
(en)
*
|
1995-02-28 |
1996-04-23 |
Eli Lilly And Company |
Benzothiophene compounds as anti-estrogenic agents
|
US5998401A
(en)
*
|
1995-02-28 |
1999-12-07 |
Eli Lilly And Company |
Naphthyl compounds, intermediates, compositions, and methods
|
PE44597A1
(es)
*
|
1995-02-28 |
1997-10-13 |
Lilly Co Eli |
Compuestos de benzotiofeno, productos intermedios, composiciones y procedimientos
|
US5919800A
(en)
*
|
1995-02-28 |
1999-07-06 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
US5705507A
(en)
*
|
1995-03-10 |
1998-01-06 |
Eli Lilly And Company |
Aplha-substituted-3-benzyl-benzofurans
|
US6391892B1
(en)
|
1995-03-10 |
2002-05-21 |
Eli Lilly And Company |
Naphthyl pharmaceutical compounds
|
US6395755B1
(en)
*
|
1995-03-10 |
2002-05-28 |
Eli Lilly And Company |
Benzothiophene pharmaceutical compounds
|
US6653328B1
(en)
|
1995-03-10 |
2003-11-25 |
Eli Lilly And Company |
3-benzyl-benzothiophenes
|
US6384053B1
(en)
|
1995-03-10 |
2002-05-07 |
Eli Lilly And Company |
α-substituted-1-benzyl-napthyls
|
US6417199B1
(en)
*
|
1995-03-10 |
2002-07-09 |
Eli Lilly And Company |
3-benzyl-benzothiophenes
|
US5523309A
(en)
*
|
1995-03-10 |
1996-06-04 |
Eli Lilly And Company |
Benzofuran pharmaceutical compounds
|
US5622974A
(en)
*
|
1995-03-10 |
1997-04-22 |
Eli Lilly And Company |
α-substituted-3-benzyl-benzofurans
|
US6451817B1
(en)
|
1995-03-10 |
2002-09-17 |
Eli Lilly And Company |
Alpha-substituted-1-benzyl-napthyls
|
AU5309096A
(en)
*
|
1995-03-13 |
1996-10-02 |
Eli Lilly And Company |
Novel benzothiophene compounds and methods
|
US5514703A
(en)
*
|
1995-03-13 |
1996-05-07 |
Eli Lilly And Company |
Benzothiophene compounds useful for inhibiting lipoxygenase
|
US5514704A
(en)
*
|
1995-03-13 |
1996-05-07 |
Eli Lilly And Company |
Benzothiophenes to inhibit leukotrienes
|
US5532382A
(en)
*
|
1995-03-13 |
1996-07-02 |
Eli Lilly And Company |
Benzothiophenes substituted at the 3-carbonyl
|
US5614639A
(en)
*
|
1995-03-31 |
1997-03-25 |
Eli Lilly And Company |
Process for preparing 2-substituted benzo[b]thiophene compounds and intermediates thereof
|
US20020091433A1
(en)
*
|
1995-04-19 |
2002-07-11 |
Ni Ding |
Drug release coated stent
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
US5837313A
(en)
*
|
1995-04-19 |
1998-11-17 |
Schneider (Usa) Inc |
Drug release stent coating process
|
CA2215902A1
(fr)
*
|
1995-04-21 |
1996-10-24 |
Charles David Jones |
Benzothiophenes a chaines laterales basiques
|
US6608090B1
(en)
|
1995-04-21 |
2003-08-19 |
Eli Lilly And Company |
Benzothiophenes with novel basic side chains
|
US5622975A
(en)
*
|
1995-06-01 |
1997-04-22 |
Eli Lilly And Company |
Methods for inhibiting vascular smooth muscle cell migration
|
US5599822A
(en)
*
|
1995-06-06 |
1997-02-04 |
Eli Lilly And Company |
Methods for minimizing bone loss
|
US5843974A
(en)
*
|
1995-06-06 |
1998-12-01 |
Eli Lilly And Company |
Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
|
AU6277396A
(en)
*
|
1995-06-07 |
1996-12-30 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
|
US5567828A
(en)
*
|
1995-06-07 |
1996-10-22 |
Eli Lilly And Company |
Compounds and compositions with nitrogen-containing non-basic side
|
US5606075A
(en)
*
|
1995-06-07 |
1997-02-25 |
Eli Lilly And Company |
Process for the synthesis of benzo[b]thiophenes
|
US6444688B1
(en)
|
1995-06-07 |
2002-09-03 |
Eli Lilly And Company |
Compounds and compositions with nitrogen-containing non-basic side chains
|
US5569772A
(en)
*
|
1995-06-07 |
1996-10-29 |
Eli Lilly And Company |
Process for the synthesis of benzo[b]thiophenes
|
US5840747A
(en)
*
|
1995-06-07 |
1998-11-24 |
Eli Lilly And Company |
Calcium channel antagonists
|
US5606076A
(en)
*
|
1995-06-07 |
1997-02-25 |
Eli Lilly And Company |
Process for the synthesis of benzo[b]thiophenes
|
DE69622472T2
(de)
*
|
1995-06-07 |
2003-02-06 |
Eli Lilly And Co., Indianapolis |
Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor
|
US5532254A
(en)
*
|
1995-06-07 |
1996-07-02 |
Eli Lilly And Company |
Modulation of calcium channels using benzothiophenes
|
US6545027B1
(en)
|
1995-06-07 |
2003-04-08 |
Eli Lilly And Company |
Methods of modulating NF-kB transcription factor
|
EP0842169B1
(fr)
|
1995-06-26 |
2001-01-03 |
Eli Lilly And Company |
Composes de benzothiofene
|
US5811421A
(en)
*
|
1995-07-31 |
1998-09-22 |
Eli Lilly And Company |
Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
|
US5728724A
(en)
*
|
1995-08-17 |
1998-03-17 |
Eli Lilly And Company |
Benzothiophene compounds
|
DE19539409C2
(de)
*
|
1995-10-11 |
1999-02-18 |
Diagnostikforschung Inst |
Kontrastmittel für die Nahinfrarot-Diagnostik
|
US5726168A
(en)
*
|
1995-10-12 |
1998-03-10 |
Eli Lilly And Company |
Lipophilic benzothiophenes
|
DE69634045T2
(de)
|
1995-10-31 |
2005-05-19 |
Eli Lilly And Co., Indianapolis |
Antithrombotische diamine
|
EP0773217A1
(fr)
*
|
1995-11-07 |
1997-05-14 |
Eli Lilly And Company |
Dérivés de benzothiophènes pour le traitement de tumeurs résistantes
|
US6113876A
(en)
*
|
1996-01-29 |
2000-09-05 |
Eli Lilly And Company |
Methods of increasing sphincter competence
|
US6432982B1
(en)
|
1996-02-21 |
2002-08-13 |
Eli Lilly And Company |
Benzothiophenes, and formulations and methods using same
|
IL120266A
(en)
*
|
1996-02-28 |
2005-05-17 |
Pfizer |
Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
|
HN1996000101A
(es)
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
EP0801066A1
(fr)
*
|
1996-03-12 |
1997-10-15 |
Eli Lilly And Company |
Benzothiophènes substitués par hétérocycles et compositions pharmaceutiques
|
US5688796A
(en)
*
|
1996-03-12 |
1997-11-18 |
Eli Lilly And Company |
Heterocyclic substituted benzothiophenes, compositions, and methods
|
WO1997034888A1
(fr)
*
|
1996-03-19 |
1997-09-25 |
Eli Lilly And Company |
SYNTHESE DE 3-[4-(2-AMINOETHOXY)BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES
|
KR100514014B1
(ko)
*
|
1996-03-26 |
2005-11-25 |
일라이 릴리 앤드 캄파니 |
벤조티오펜,그를함유한제제및방법
|
ES2341399T3
(es)
*
|
1996-03-26 |
2010-06-18 |
Eli Lilly And Company |
Benziotofenos, formulaciones que contienen los mismos y procedimientos.
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
US5747509A
(en)
*
|
1996-06-03 |
1998-05-05 |
Schering Aktiengesellschaft |
Method for lowering plasma levels of lipoprotein(a)
|
US6110942A
(en)
*
|
1996-06-17 |
2000-08-29 |
Eli Lilly And Company |
Method for minimizing the uterotrophic effect of droloxifene
|
US6350884B1
(en)
|
1996-06-25 |
2002-02-26 |
Eli Lilly And Company |
Acrylic and propionic acid compounds, intermediates, processes, compositions, and method
|
CA2206752A1
(fr)
|
1996-07-02 |
1998-01-02 |
George Joseph Cullinan |
Composes de benzothiophene,intermediaires, procedes et methodes d'utilisation
|
CA2207141A1
(fr)
*
|
1996-07-15 |
1998-01-15 |
David Thompson Berg |
Composes de benzothiophene,formulations et utilisations de ceux-ci
|
CA2207083A1
(fr)
*
|
1996-07-15 |
1998-01-15 |
Brian William Grinnell |
Composes de benzothiophene, formulations et utilisations de ceux-ci
|
US5672609A
(en)
*
|
1996-07-18 |
1997-09-30 |
Eli Lilly And Company |
Pyridine compounds, intermediates compositions and methods of use
|
US5792798A
(en)
*
|
1996-07-29 |
1998-08-11 |
Eli Lilly And Company |
Method for inhibiting plasminogen activator inhibitor 1
|
US6713494B1
(en)
|
1996-08-28 |
2004-03-30 |
Eli Lilly And Company |
Amorphous benzothiophenes, methods of preparation and methods of use
|
ID19392A
(id)
*
|
1996-08-29 |
1998-07-09 |
Lilly Co Eli |
Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
|
US6599920B2
(en)
|
1996-08-29 |
2003-07-29 |
Eli Lilly And Company |
Naphthalene compounds, intermediates, formulations, and methods
|
CA2214070C
(fr)
*
|
1996-08-29 |
2006-03-14 |
Eli Lilly And Company |
Dihydronaphtalenes et naphtalenes, intermediaires, formulations et methodes
|
CA2213810C
(fr)
*
|
1996-08-29 |
2006-06-06 |
Lewis Dale Pennington |
Benzo¬b|thiophenes, intermediaires, procedes, compositions et methodes
|
CA2214072C
(fr)
*
|
1996-08-29 |
2006-11-14 |
Eli Lilly And Company |
Benzo [b] thiophenes, intermediaires, procedes, compositions et methodes
|
CA2214919A1
(fr)
*
|
1996-09-24 |
1998-03-24 |
Kenneth Lee Hauser |
Composes de benzothiophene, intermediaires, procedes, compositions et methodes
|
IN183239B
(fr)
*
|
1996-09-25 |
1999-10-09 |
Lilly Co Eli |
|
CA2214935A1
(fr)
*
|
1996-09-26 |
1998-03-26 |
Henry Uhlman Bryant |
Benzofluorenes, intermediaires, compositions et methodes
|
CA2214929A1
(fr)
*
|
1996-09-26 |
1998-03-26 |
Charles Willis Lugar, Iii |
Naphtofluorenes, intermediaires, compositions et methodes
|
CA2215856A1
(fr)
*
|
1996-09-26 |
1998-03-26 |
Eli Lilly And Company |
Dihydrobenzofluorenes, intermediaires, compositions et methodes
|
CA2214931A1
(fr)
*
|
1996-09-26 |
1998-03-26 |
Henry Uhlman Bryant |
Tetrahydrobenzo-a-fluorenes et methode d'utilisation
|
CA2214196A1
(fr)
*
|
1996-09-26 |
1998-03-26 |
Eli Lilly And Company |
Composes de dihydrobenzo[b]indeno[2,1-d]thiophene, intermediaires, procedes, compositions et methodes
|
CA2214922A1
(fr)
*
|
1996-09-27 |
1998-03-27 |
Eli Lilly And Company |
Composes de benzothiofene, compositions et methodes
|
US5916916A
(en)
*
|
1996-10-10 |
1999-06-29 |
Eli Lilly And Company |
1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
|
US5958969A
(en)
*
|
1996-10-10 |
1999-09-28 |
Eli Lilly And Company |
Benzo b!thiophene compounds, intermediates, formulations, and methods
|
US5948796A
(en)
*
|
1996-10-10 |
1999-09-07 |
Eli Lilly And Company |
Benzo B!thiophene compounds, intermediates, formulations, and methods
|
CA2216592C
(fr)
*
|
1996-10-24 |
2006-07-18 |
Brian Stephen Muehl |
Composes a base de benzothiophene, intermediaires, compositions et methodes
|
CA2215647A1
(fr)
*
|
1996-10-24 |
1998-04-24 |
Eli Lilly And Company |
Composes a base de naphtyle, compositions et methodes
|
CA2214872C
(fr)
*
|
1996-10-24 |
2002-01-22 |
Eli Lilly And Company |
Composes a base de benzothiophene, compositions et methodes
|
ZA992858B
(en)
|
1996-10-30 |
1999-07-29 |
Lilly Co Eli |
Methods of preventing breast cancer.
|
US5773432A
(en)
*
|
1996-10-30 |
1998-06-30 |
Schering Aktiengesellschaft |
Method for lowering plasma levels of lipoprotein(a)
|
ZA9710262B
(en)
*
|
1996-11-19 |
1999-05-13 |
Lilly Co Eli |
Process for the synthesis of benzothiophenes
|
US5886025A
(en)
*
|
1997-03-06 |
1999-03-23 |
Baylor University |
Anti-mitotic agents which inhibit tubulin polymerization
|
ZA982877B
(en)
*
|
1997-04-09 |
1999-10-04 |
Lilly Co Eli |
Treatment of central nervous system disorders with selective estrogen receptor modulators.
|
AU6959898A
(en)
|
1997-04-11 |
1998-11-11 |
David J. Grainger |
Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
|
US6025373A
(en)
*
|
1997-04-22 |
2000-02-15 |
Eli Lilly And Company |
Methods for reducing fibrinogen
|
WO1998048806A1
(fr)
*
|
1997-04-25 |
1998-11-05 |
Eli Lilly And Company |
Composes d'indene servant de modulateurs serm
|
WO1998048793A1
(fr)
*
|
1997-04-30 |
1998-11-05 |
Eli Lilly And Company |
INTERMEDIAIRES ET PROCEDES DE PREPARATION DE BENZO[b]THIOPHENES
|
WO1998048792A1
(fr)
*
|
1997-04-30 |
1998-11-05 |
Eli Lilly And Company |
PROCEDE D'ALKYLATION REGIOSELECTIVE POUR LA PREPARATION DE BENZO[b]THIOPHENES SUBSTITUES
|
AU7563598A
(en)
*
|
1997-04-30 |
1998-11-24 |
Eli Lilly And Company |
Antithrombotic agents
|
AU7470098A
(en)
|
1997-04-30 |
1998-11-24 |
Eli Lilly And Company |
Antithrombotic agents
|
CN1253556A
(zh)
*
|
1997-04-30 |
2000-05-17 |
伊莱利利公司 |
制备苯并噻吩的方法
|
JP2001524114A
(ja)
*
|
1997-04-30 |
2001-11-27 |
イーライ・リリー・アンド・カンパニー |
ベンゾ[b]チオフェン類の製造における中間体および方法
|
CA2288144A1
(fr)
*
|
1997-04-30 |
1998-11-05 |
Eli Lilly And Company |
Agents antithrombotiques
|
CA2236254A1
(fr)
*
|
1997-04-30 |
1998-10-30 |
David Warren Hoard |
Methode de preparation de benzo[b]thiophenes
|
AU7274198A
(en)
|
1997-04-30 |
1998-11-24 |
Eli Lilly And Company |
Antithrombotic agents
|
CA2231013A1
(fr)
*
|
1997-04-30 |
1998-10-30 |
Eli Lilly And Company |
Methode pour preparer des intermediaires derives de l'acid benzoique et des produits pharmaceutiques a base de benzothiophene
|
JP2002513415A
(ja)
|
1997-04-30 |
2002-05-08 |
イーライ・リリー・アンド・カンパニー |
抗血栓剤
|
AU735703B2
(en)
*
|
1997-06-10 |
2001-07-12 |
Karo Bio Ab |
Estrogen receptor ligands
|
US20030032779A1
(en)
*
|
1997-06-10 |
2003-02-13 |
Lars Ohman |
Estrogen receptor ligands
|
US5760030A
(en)
*
|
1997-06-30 |
1998-06-02 |
Eli Lilly And Company |
Benzothiophene compounds and methods of use
|
US6653297B1
(en)
*
|
1997-07-03 |
2003-11-25 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
JP2001513501A
(ja)
|
1997-08-07 |
2001-09-04 |
イーライ・リリー・アンド・カンパニー |
エストロゲン阻害活性を有する1−[4−(置換アルコキシ)ベンジル]ナフタレン化合物
|
US6090843A
(en)
*
|
1997-08-11 |
2000-07-18 |
Eli Lilly And Company |
Benzothiophenes compounds which have useful pharmaceutical activity
|
US5908859A
(en)
*
|
1997-08-11 |
1999-06-01 |
Eli Lilly And Company |
Benzothiophenes for inhibiting hyperlipidemia
|
US6008232A
(en)
*
|
1997-08-20 |
1999-12-28 |
Eli Lilly And Company |
Methods for preventing headaches
|
US6103740A
(en)
*
|
1997-08-21 |
2000-08-15 |
Eli Lilly And Company |
Methods for lowering platelet counts
|
US6096764A
(en)
*
|
1997-08-21 |
2000-08-01 |
Eli Lilly And Company |
Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
|
US6017914A
(en)
*
|
1997-09-03 |
2000-01-25 |
Eli Lilly And Company |
Benzo[b]thiophene compounds, intermediates, formulations, and methods
|
US5929090A
(en)
*
|
1997-09-12 |
1999-07-27 |
Eli Lilly And Company |
2-aryl-3-aminoaryloxynaphthy1 compounds, intermediates, compositions and methods
|
US5834488A
(en)
*
|
1997-09-19 |
1998-11-10 |
Eli Lilly And Company |
Dihydrobenzo B! indeno 2, 1-D! thiophene compounds, intermediates, processes, compositions and methods
|
US5990129A
(en)
*
|
1997-09-23 |
1999-11-23 |
Eli Lilly And Company |
Methods for regulating trkA expression
|
CA2306489A1
(fr)
|
1997-10-03 |
1999-04-15 |
Mark Gregory Stocksdale |
Benzothiophenes
|
ID24978A
(id)
*
|
1997-11-14 |
2000-08-31 |
Lilly Co Eli |
2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
|
US6096781A
(en)
|
1997-11-14 |
2000-08-01 |
Eli Lilly And Company |
2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
|
NZ507151A
(en)
*
|
1998-04-08 |
2002-11-26 |
Lilly Co Eli |
Pulmonary and nasal delivery of raloxifene
|
FR2777784B1
(fr)
*
|
1998-04-27 |
2004-03-19 |
Arepa |
Composition pharmaceutique a base d'estrogene et de progesterone
|
US6284756B1
(en)
|
1998-04-30 |
2001-09-04 |
Eli Lilly And Company |
Antithrombotic agents
|
US6110963A
(en)
*
|
1998-05-12 |
2000-08-29 |
American Home Products Corporation |
Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
DE19826213A1
(de)
*
|
1998-06-09 |
1999-12-16 |
Schering Ag |
Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
US6353003B1
(en)
|
1998-06-17 |
2002-03-05 |
Eli Lilly And Company |
Method for reducing levels of homocysteine and C-reactive protein
|
US6060488A
(en)
*
|
1998-09-22 |
2000-05-09 |
Eli Lilly And Company |
Benzothiophenes for treating estrogen deficiency
|
US6258826B1
(en)
|
1998-10-13 |
2001-07-10 |
Eli Lilly And Company |
Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
|
CA2287549A1
(fr)
*
|
1998-10-28 |
2000-04-28 |
Jefferson Ray Mccowan |
Antithrombotiques
|
US7001926B2
(en)
*
|
2000-03-10 |
2006-02-21 |
Oxigene, Inc. |
Tubulin binding agents and corresponding prodrug constructs
|
US6300367B1
(en)
|
1999-04-20 |
2001-10-09 |
Protein Technologies International, Inc. |
Composition for and method of preventing or treating breast cancer
|
US6849656B1
(en)
|
1999-09-17 |
2005-02-01 |
Baylor University |
Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
|
EP1113007A1
(fr)
*
|
1999-12-24 |
2001-07-04 |
Pfizer Inc. |
Composés de tétrahydroisoquinoline comme agonistes/antagonistes d'oestrogène
|
US7091240B2
(en)
*
|
2000-03-10 |
2006-08-15 |
Oxigene, Inc. |
Tubulin binding ligands and corresponding prodrug constructs
|
AR029538A1
(es)
*
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Composiciones farmaceuticas de agentes estrogenicos
|
AU2002230409A1
(en)
*
|
2000-11-27 |
2002-06-03 |
Eli Lilly And Company |
Process for preparing 3-aryl-benzo(b)thiophenes
|
WO2002072549A1
(fr)
*
|
2001-03-12 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Heterocycles fonctionnalises en tant que modulateurs de la fonction du recepteur de chimiokines et procedes de mise en oeuvre
|
US6613083B2
(en)
*
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
US7425565B2
(en)
*
|
2002-05-09 |
2008-09-16 |
Cedars-Sinai Medical Center |
Use of benzothiopenes to treat and prevent prostate cancer
|
EP1395563B1
(fr)
*
|
2001-05-22 |
2006-03-29 |
Eli Lilly And Company |
1,2,3,4-tetrahydroquinoline 2-substituees et leurs derives, ainsi que leurs composition et leurs procedes
|
US6962928B2
(en)
*
|
2001-05-22 |
2005-11-08 |
Eli Lilly And Company |
Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
|
US20030216358A1
(en)
*
|
2001-07-05 |
2003-11-20 |
Muchmore Douglas Boyer |
Method for enhancing bone mineral density gain
|
EP1546138B1
(fr)
*
|
2002-09-30 |
2012-01-18 |
A/S GEA Farmaceutisk Fabrik |
L-lactate de raloxifène ou un hémihydrate de celui-ci, leurs utilisations, compositions pharmaceutiques et procédés de préparation
|
AU2003292625B2
(en)
|
2002-12-26 |
2008-07-24 |
Eisai R & D Management Co., Ltd. |
Selective estrogen receptor modulators
|
TWI299664B
(en)
*
|
2003-01-06 |
2008-08-11 |
Osi Pharm Inc |
(2-carboxamido)(3-amino)thiophene compounds
|
US7332525B2
(en)
*
|
2003-01-17 |
2008-02-19 |
Castle Erik P |
Method of treatment of prostate cancer and composition for treatment thereof
|
CN1548434B
(zh)
*
|
2003-05-16 |
2010-07-28 |
中国科学院上海药物研究所 |
一类苯并噻吩类化合物、及制备和它的医药用途
|
US20060106010A1
(en)
*
|
2003-05-27 |
2006-05-18 |
Black Larry J |
Methods for inhibiting bone loss
|
US20040248989A1
(en)
|
2003-06-05 |
2004-12-09 |
Risto Santti |
Method for the treatment or prevention of lower urinary tract symptoms
|
DE10349249A1
(de)
*
|
2003-10-20 |
2005-05-12 |
Basf Ag |
Verfahren zur Herstellung von alpha-(3-Arylthio)-acetophenonen
|
US7012153B2
(en)
|
2003-12-22 |
2006-03-14 |
Eli Lilly And Company |
Process for preparing benzoic acids
|
FR2864536B1
(fr)
*
|
2003-12-24 |
2006-03-17 |
Clariant France Sa |
Procede de preparation de n-alkyl-2 (hydroxy-4-benzoyl)-3 benzofurannes et intermediaires pour sa mise en oeuvre
|
CN100339383C
(zh)
*
|
2004-02-27 |
2007-09-26 |
中国科学院上海药物研究所 |
骨靶向药物、合成方法及用途
|
RU2400227C2
(ru)
*
|
2004-04-08 |
2010-09-27 |
Вайет |
Состав, содержащий твердую дисперсию базедоксифен ацетата
|
WO2005100315A1
(fr)
*
|
2004-04-08 |
2005-10-27 |
Wyeth |
Ascorbate de bazedoxifene utile en tant que modulateur selectif des recepteurs d'oestrogene
|
US7456214B2
(en)
*
|
2004-05-03 |
2008-11-25 |
Baylor University |
Chromene-containing compounds with anti-tubulin and vascular targeting activity
|
US20050245489A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Pinney Kevin G |
Chromene-containing compounds with anti-tubulin and vascular targeting activity
|
US20060293294A1
(en)
*
|
2004-09-03 |
2006-12-28 |
Hormos Medical Corporation |
Method for treatment or prevention of androgen deficiency
|
AP2007003979A0
(en)
*
|
2004-11-23 |
2007-06-30 |
Warner Lambert Co |
7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
IN2014MN00380A
(fr)
|
2006-06-30 |
2015-06-19 |
Iceutica Pty Ltd |
|
WO2008047105A1
(fr)
*
|
2006-10-17 |
2008-04-24 |
Cipla Limited |
Forme cristalline de composé benzothiophène et procédé d'élaboration correspondant
|
JP5498168B2
(ja)
|
2006-12-01 |
2014-05-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
|
KR100803746B1
(ko)
|
2006-12-14 |
2008-02-15 |
하나제약 주식회사 |
랄록시펜의 신규한 제조 방법
|
JP5558358B2
(ja)
|
2007-10-16 |
2014-07-23 |
レプロス セラピューティクス インコーポレイティド |
メタボリック症候群用のtrans−クロミフェン
|
CA2759125C
(fr)
|
2009-04-24 |
2017-08-15 |
Iceutica Pty Ltd |
Nouvelle formulation d'indomethacine
|
EP2314581B1
(fr)
|
2009-10-23 |
2012-07-25 |
Hexal AG |
Procédé de préparation de dérivés de benzo[b]thiophène
|
EP2322519A1
(fr)
|
2009-10-23 |
2011-05-18 |
Hexal AG |
Procédé de préparation de dérivés de benzo[b]thiophène
|
US8501690B2
(en)
|
2010-04-30 |
2013-08-06 |
John G. Stark |
Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
|
CA2864104A1
(fr)
|
2012-02-14 |
2013-08-22 |
Repros Therapeutics Inc. |
Modulateurs selectifs des recepteurs d'strogenes a demi-vies courtes et leurs utilisations
|
CA2865234A1
(fr)
|
2012-02-29 |
2013-09-06 |
Repros Therapeutics Inc. |
Polytherapie pour le traitement d'une carence en androgene
|
ZA201401636B
(en)
|
2013-03-05 |
2014-11-26 |
Cipla Ltd |
Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
|
ES2939940T3
(es)
|
2014-03-28 |
2023-04-28 |
Univ Duke |
Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
|
US9421264B2
(en)
|
2014-03-28 |
2016-08-23 |
Duke University |
Method of treating cancer using selective estrogen receptor modulators
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
EP3789027A1
(fr)
|
2015-01-13 |
2021-03-10 |
Kyoto University |
Bosutinib, sunitinib, tivozanib, imatinib, nilotinib, rebastinib ou bafetinib pour la prévention et/ou le traitement de la sclérose latérale amyotrophique
|
CN107206011B
(zh)
|
2015-01-28 |
2020-10-20 |
韩美药品株式会社 |
包括雷洛昔芬以及维生素d或其衍生物的复合胶囊
|
WO2016165007A1
(fr)
*
|
2015-04-17 |
2016-10-20 |
The University Of British Columbia |
Inhibiteurs du récepteur d'œstrogène alpha et leur utilisation en tant qu'agents thérapeutiques pour le cancer
|
AU2016352592B2
(en)
|
2015-11-10 |
2023-04-27 |
Paracrine Therapeutics Ab |
Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen
|
WO2017100715A1
(fr)
|
2015-12-09 |
2017-06-15 |
The Board Of Trustees Of The University Of Illinois |
Composés régulateurs à la baisse des récepteurs des œstrogènes sélectifs à base de benzothiophène
|
WO2018081168A2
(fr)
|
2016-10-24 |
2018-05-03 |
The Board Of Trustees Of The University Of Illinois |
Répresseurs du récepteur oestrogénique sélectifs mixtes à base de benzothiophène
|
TWI619697B
(zh)
|
2016-12-01 |
2018-04-01 |
國立中山大學 |
亞碸化合物及其用於製造苯並噻吩衍生物之方法
|
NZ754865A
(en)
|
2017-01-06 |
2023-07-28 |
G1 Therapeutics Inc |
Combination therapy for the treatment of cancer
|
KR20190117582A
(ko)
|
2017-02-10 |
2019-10-16 |
쥐원 쎄라퓨틱스, 인크. |
벤조티오펜 에스트로겐 수용체 조정제
|
AU2019223014B2
(en)
|
2018-02-21 |
2024-10-17 |
AI Therapeutics, Inc. |
Combination therapy with apilimod and glutamatergic agents
|